Insomnia

The Lancet, Год журнала: 2022, Номер 400(10357), С. 1047 - 1060

Опубликована: Сен. 1, 2022

Язык: Английский

---

Cognitive behavioral therapy for insomnia in patients with mental disorders and comorbid insomnia: A systematic review and meta-analysis

Sleep Medicine Reviews, Год журнала: 2022, Номер 62, С. 101597 - 101597

Опубликована: Фев. 9, 2022

Almost 70% of patients with mental disorders report sleep difficulties and 30% fulfill the criteria for insomnia disorder. Cognitive behavioral therapy (CBT-I) is first-line treatment according to current guidelines. Despite this circumstance, frequently treated only pharmacologically especially in disorders. The aim present meta-analysis was quantify effects CBT-I comorbid on two outcome parameters: severity health. databases PubMed, CINHAL (Ebsco) und PsycINFO (Ovid) were searched randomized controlled trials adult any disorder comparing placebo, waitlist or as usual using self-rating questionnaires outcomes either health both. search resulted 1994 records after duplicate removal which 22 fulfilled inclusion included meta-analysis. comorbidities depression (eight studies, 491 patients), post-traumatic stress (PTSD, four 216 alcohol dependency (three 79 bipolar (one study, 58 psychosis 50 patients) mixed within one study (five 189 patients). effect sizes reduction post 0.5 (confidence interval, CI, 0.3-0.8) depression, 1.5 (CI 1.0-1.9) PTSD, 1.4 0.9-1.9) dependency, 1.2 0.8-1.7) psychosis/bipolar disorder, 0.8 0.1-1.6) comorbidities. Effect moderate large at follow-up. Regarding symptom severity, directly 0.1-0.8) 1.3 0.6-1.9) 0.9 0.3-1.4) 0.3 -0.1 - 0.7, insignificant) psychosis/bipolar, 0.1-1.5) There no significant symptoms Together, these significant, stable medium indicate that an effective a PTSD dependency. also add-on improving outpatients diagnoses. Thus, insomnia, given many side medication, should be considered treatment.

Язык: Английский

---

We know CBT-I works, now what?

Faculty Reviews, Год журнала: 2022, Номер 11

Опубликована: Фев. 1, 2022

Cognitive behavioral therapy for insomnia (CBT-I) has been shown to be efficacious and now is considered the first-line treatment both uncomplicated that occurs comorbidly with other chronic disorders (comorbid insomnia). The purposes of this review are provide a comprehensive summary efficacy data (for example, overall by clinical demographic considerations CBT-I formulation) discuss future what next steps should taken in terms research, dissemination, implementation, practice).

Язык: Английский

---

Non-pharmacological Approaches for Management of Insomnia

Neurotherapeutics, Год журнала: 2021, Номер 18(1), С. 32 - 43

Опубликована: Янв. 1, 2021

Язык: Английский

---

Cognitive Behavioral Therapy for Insomnia across the Spectrum of Alcohol Use Disorder: A Systematic Review and Meta-Analysis

Sleep Medicine Reviews, Год журнала: 2025, Номер 80, С. 102049 - 102049

Опубликована: Янв. 11, 2025

Язык: Английский

---

Sleep disturbance as a therapeutic target to improve opioid use disorder treatment.

Experimental and Clinical Psychopharmacology, Год журнала: 2021, Номер 30(6), С. 1024 - 1035

Опубликована: Июнь 10, 2021

Sleep health is an important factor across several physical and mental disorders, a growing scientific consensus has identified sleep as critical component of opioid use disorder (OUD), both in the active disease state during OUD recovery. The goal this narrative review to collate literature on sleep, use, means identifying therapeutic targets improve treatment outcomes. disturbance common often severe persons with OUD, especially withdrawal, but also maintenance therapies. There ample evidence that disturbances including reduced total time, disrupted continuity, poor quality accompany negative are bidirectionally associated other factors related outcomes, chronic stress, stress reactivity, low positive affect, high pain, drug craving. This constellation outcome variables represents more comprehensive appraisal life recovery than typically assessed clinical trials. To date, there very few trials or experimental studies aimed at improving patients, either craving potential mechanistic target reduce withdrawal behaviors. As such, direct impact improvement patients largely unknown, yet research suggests interventions promising avenue treatment. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

Язык: Английский

---

Approaches to the assessment of adherence to CBT-I, predictors of adherence, and the association of adherence to outcomes: A systematic review

Sleep Medicine Reviews, Год журнала: 2022, Номер 63, С. 101620 - 101620

Опубликована: Март 4, 2022

Язык: Английский

---

Pharmacological and Nonpharmacological Interventions to Address Sleep Disturbance in Substance use Disorders

Current Sleep Medicine Reports, Год журнала: 2025, Номер 11(1)

Опубликована: Янв. 29, 2025

Язык: Английский

---

Cultural adaptations of psychological interventions for prevalent sleep disorders and sleep disturbances: A systematic review of randomized controlled trials in the United States

Sleep Medicine Reviews, Год журнала: 2021, Номер 56, С. 101455 - 101455

Опубликована: Фев. 9, 2021

Язык: Английский

---

Strengthening Neuroplasticity in Substance Use Recovery Through Lifestyle Intervention

American Journal of Lifestyle Medicine, Год журнала: 2024, Номер 18(5), С. 648 - 656

Опубликована: Март 30, 2024

The incidence of substance use and behavioral addictions continues to increase throughout the world. Global Burden Disease Study shows a growing impact in disability-adjusted life years due use. Substance impacts families, communities, health care, legal systems; yet, vast majority individuals with disorders do not seek treatment. Within United States, new legislation has attempted availability buprenorphine, but continues. Although medications group support therapy have been mainstay treatment for use, lifestyle medicine offers valuable adjunct that may help strengthen recovery through healthy neuroplastic changes.

Язык: Английский

---